Clin2
NCT05829655Possibly a fitRecruiting

Measuring drug cravings in people with opioid use disorder

Opioid Use DisorderOpioid Dependence

Treatments studied

Part of Mental health clinical trials.

This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
75 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with moderate or severe opioid use disorder
  • You are in good general health and have been cleared by a doctor
  • You are not currently seeking treatment for opioid use
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07128524Recruiting· Phase 2
Ketones for opioid craving study

This trial tests if a ketone supplement can help reduce cravings during opioid withdrawal treatment. Participants take the supplement daily and are monitored for changes in craving and withdrawal symptoms.

Wernersville, Pennsylvania
NCT05027919Recruiting· Phase 2
Testing ways to predict opioid withdrawal during a taper

This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.

Baltimore, Maryland
NCT05511909Recruiting· Phase 2
Buspirone study for opioid withdrawal symptoms

This Phase 2 study tests whether buspirone can help reduce symptoms during opioid detox (withdrawal). You may be able to take part if you have opioid withdrawal and are planning medically supervised detox.

Baltimore, Maryland
NCT07094672Not yet recruiting
Opioid withdrawal symptom study

This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.

Baltimore, Maryland
NCT04379115Recruiting
Brain stimulation study for people with opioid addiction

This study tests a non-invasive brain stimulation approach to reduce opioid cravings in people who are actively using non-prescribed opioids while on stable methadone. It may help people feel less craving and improve recovery support.

Hinsdale, Illinois
NCT06021548Recruiting
Opioid addiction markers study

This study looks at physical, psychological, and social factors that may be linked to opioid addiction. It aims to better understand addiction to help improve future treatments.

Bron

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.